| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Angiolymphatic invasion exerts a strong impact on surgical outcomes for stage I lung adenocarcinoma, but not non-adenocarcinoma
|
Kato, Tatsuya
|
|
2012
|
77 |
2 |
p. 394-400
7 p.
|
artikel
|
| 2 |
Aspirin and non-aspirin non-steroidal anti-inflammatory drug use and risk of lung cancer
|
Lim, Wei-Yen
|
|
2012
|
77 |
2 |
p. 246-251
6 p.
|
artikel
|
| 3 |
Characterization of vitamin D receptor (VDR) in lung adenocarcinoma
|
Kim, So Hee
|
|
2012
|
77 |
2 |
p. 265-271
7 p.
|
artikel
|
| 4 |
Chemotherapy for pulmonary large cell neuroendocrine carcinoma: Similar to that for small cell lung cancer or non-small cell lung cancer?
|
Sun, Jong-Mu
|
|
2012
|
77 |
2 |
p. 365-370
6 p.
|
artikel
|
| 5 |
Clinical and molecular analysis of synchronous double lung cancers
|
Arai, Junichi
|
|
2012
|
77 |
2 |
p. 281-287
7 p.
|
artikel
|
| 6 |
Clinicoradiologic characteristics of patients with lung adenocarcinoma harboring EML4-ALK fusion oncogene
|
Fukui, Takayuki
|
|
2012
|
77 |
2 |
p. 319-325
7 p.
|
artikel
|
| 7 |
Contents
|
|
|
2012
|
77 |
2 |
p. vi-viii
nvt p.
|
artikel
|
| 8 |
Corrigendum to “Lipid raft modulation inhibits NSCLC cell migration through delocalization of the focal adhesion complex” [Lung Cancer 69 (2010) 165–171]
|
Jeon, Jeong Hee
|
|
2012
|
77 |
2 |
p. 473-
1 p.
|
artikel
|
| 9 |
Detection of EML4-ALK fusion genes in a few cancer cells from transbronchial cytological specimens utilizing immediate cytology during bronchoscopy
|
Kanaji, Nobuhiro
|
|
2012
|
77 |
2 |
p. 293-298
6 p.
|
artikel
|
| 10 |
Differential sensitivities to tyrosine kinase inhibitors in NSCLC harboring EGFR mutation and ALK translocation
|
Lee, June Koo
|
|
2012
|
77 |
2 |
p. 460-463
4 p.
|
artikel
|
| 11 |
EBUS-TBNA in patients presented with superior vena cava syndrome
|
Wong, Matthew K.
|
|
2012
|
77 |
2 |
p. 277-280
4 p.
|
artikel
|
| 12 |
Editorial Board
|
|
|
2012
|
77 |
2 |
p. iv-
1 p.
|
artikel
|
| 13 |
Efficacy and safety of maintenance erlotinib in Asian patients with advanced non-small-cell lung cancer: A subanalysis of the phase III, randomized SATURN study
|
Wu, Yi-Long
|
|
2012
|
77 |
2 |
p. 339-345
7 p.
|
artikel
|
| 14 |
EGFR mutations as a predictive marker of cytotoxic chemotherapy
|
Park, Jin Hyun
|
|
2012
|
77 |
2 |
p. 433-437
5 p.
|
artikel
|
| 15 |
ERCC1 expression in circulating tumor cells (CTCs) using a novel detection platform correlates with progression-free survival (PFS) in patients with metastatic non-small-cell lung cancer (NSCLC) receiving platinum chemotherapy
|
Das, Millie
|
|
2012
|
77 |
2 |
p. 421-426
6 p.
|
artikel
|
| 16 |
Expression and prognostic significance of centromere protein A in human lung adenocarcinoma
|
Wu, Qing
|
|
2012
|
77 |
2 |
p. 407-414
8 p.
|
artikel
|
| 17 |
Hepatoid Pancoast tumor. A case report and review of the literature
|
Papatsimpas, Georgios
|
|
2012
|
77 |
2 |
p. 239-245
7 p.
|
artikel
|
| 18 |
Immunohistochemical screening for anaplastic lymphoma kinase (ALK) rearrangement in advanced non-small cell lung cancer patients
|
Park, Heae Surng
|
|
2012
|
77 |
2 |
p. 288-292
5 p.
|
artikel
|
| 19 |
Impact of non-small cell lung cancer histology on survival predicted from the graded prognostic assessment for patients with brain metastases
|
Guo, Susan
|
|
2012
|
77 |
2 |
p. 389-393
5 p.
|
artikel
|
| 20 |
Increase of regulatory T cells in metastatic stage and CTLA-4 over expression in lymphocytes of patients with non-small cell lung cancer (NSCLC)
|
Erfani, Nasrollah
|
|
2012
|
77 |
2 |
p. 306-311
6 p.
|
artikel
|
| 21 |
Inhibition of RalA signaling pathway in treatment of non-small cell lung cancer
|
Male, Heather
|
|
2012
|
77 |
2 |
p. 252-259
8 p.
|
artikel
|
| 22 |
Loss of heterozygosity of the Mutated in Colorectal Cancer gene is not associated with promoter methylation in non-small cell lung cancer
|
Poursoltan, Pirooz
|
|
2012
|
77 |
2 |
p. 272-276
5 p.
|
artikel
|
| 23 |
National survey of the medical treatment status for non-small cell lung cancer (NSCLC) in China
|
Xue, Cong
|
|
2012
|
77 |
2 |
p. 371-375
5 p.
|
artikel
|
| 24 |
Non-steroidal anti-inflammatory drugs and small cell lung cancer risk in the VITAL study
|
Brasky, Theodore M.
|
|
2012
|
77 |
2 |
p. 260-264
5 p.
|
artikel
|
| 25 |
Overexpression and potential targeting of the oncofoetal antigen 5T4 in malignant pleural mesothelioma
|
Al-Taei, Saly
|
|
2012
|
77 |
2 |
p. 312-318
7 p.
|
artikel
|
| 26 |
Peroxiredoxins and tropomyosins as plasma biomarkers for lung cancer and asbestos exposure
|
Rostila, Annina
|
|
2012
|
77 |
2 |
p. 450-459
10 p.
|
artikel
|
| 27 |
Phase II study of maintenance sunitinib following irinotecan and carboplatin as first-line treatment for patients with extensive-stage small-cell lung cancer
|
Spigel, David R.
|
|
2012
|
77 |
2 |
p. 359-364
6 p.
|
artikel
|
| 28 |
Prediction of copper transport protein 1 (CTR1) genotype on severe cisplatin induced toxicity in non-small cell lung cancer (NSCLC) patients
|
Xu, Xiaojing
|
|
2012
|
77 |
2 |
p. 438-442
5 p.
|
artikel
|
| 29 |
Prognostic factors in patients with advanced non-small cell lung cancer: Data from the phase III FLEX study
|
Pirker, R.
|
|
2012
|
77 |
2 |
p. 376-382
7 p.
|
artikel
|
| 30 |
Prognostic impact of nestin expression in resected large cell neuroendocrine carcinoma of the lung
|
Ryuge, Shinichiro
|
|
2012
|
77 |
2 |
p. 415-420
6 p.
|
artikel
|
| 31 |
Prospective study of transarterial infusion of docetaxel and cisplatin to treat non-small-cell lung cancer in patients contraindicated for standard chemotherapy
|
Nakanishi, Masanori
|
|
2012
|
77 |
2 |
p. 353-358
6 p.
|
artikel
|
| 32 |
Proteomics-based identification of secreted protein dihydrodiol dehydrogenase 2 as a potential biomarker for predicting cisplatin efficacy in advanced NSCLC patients
|
Kuang, Peng
|
|
2012
|
77 |
2 |
p. 427-432
6 p.
|
artikel
|
| 33 |
Randomized phase II trial of first-line treatment with pemetrexed-cisplatin, followed sequentially by gefitinib or pemetrexed, in East Asian, never-smoker patients with advanced non-small cell lung cancer
|
Ahn, Myung-Ju
|
|
2012
|
77 |
2 |
p. 346-352
7 p.
|
artikel
|
| 34 |
Reduced expression of cyclin D2 is associated with poor recurrence-free survival independent of cyclin D1 in stage III non-small cell lung cancer
|
Ko, Eunkyung
|
|
2012
|
77 |
2 |
p. 401-406
6 p.
|
artikel
|
| 35 |
Risk factors for radiation-induced lung toxicity in patients with non-small cell lung cancer who received postoperative radiation therapy
|
Zhao, Lujun
|
|
2012
|
77 |
2 |
p. 326-330
5 p.
|
artikel
|
| 36 |
Single agent maintenance therapy for advanced stage non-small cell lung cancer: A meta-analysis
|
Behera, Madhusmita
|
|
2012
|
77 |
2 |
p. 331-338
8 p.
|
artikel
|
| 37 |
Successful erlotinib rechallenge for leptomeningeal metastases of lung adenocarcinoma after erlotinib-induced interstitial lung disease: A case report and review of the literature
|
Togashi, Yosuke
|
|
2012
|
77 |
2 |
p. 464-468
5 p.
|
artikel
|
| 38 |
The Glasgow Prognostic Score (GPS) predicts toxicity and efficacy in platinum-based treated patients with metastatic lung cancer
|
Gioulbasanis, Ioannis
|
|
2012
|
77 |
2 |
p. 383-388
6 p.
|
artikel
|
| 39 |
Use of erlotinib throughout pregnancy: A case-report of a patient with metastatic lung adenocarcinoma
|
Rivas, Giovanna
|
|
2012
|
77 |
2 |
p. 469-472
4 p.
|
artikel
|
| 40 |
Use of mutation specific antibodies to detect EGFR status in small biopsy and cytology specimens of lung adenocarcinoma
|
Hasanovic, Adnan
|
|
2012
|
77 |
2 |
p. 299-305
7 p.
|
artikel
|
| 41 |
VEGF and sVEGFR-1 in malignant pleural effusions: Association with survival and pleurodesis outcomes
|
Hooper, C.E.
|
|
2012
|
77 |
2 |
p. 443-449
7 p.
|
artikel
|
Tijdschrift beschrijving